Antimicrobial Agents and Chemotherapy · 2020 · 11 citations · 23 references
MedicinePharmacokineticsPharmacologyClinical PharmacologyDrug ClearanceMaternal-fetal MedicinePerinatal PharmacologyPregnancy PharmacologyArea Under The Concentration - Time CurveArea Under The Plasma Concentration-time CurveGestational PharmacokineticsHigh-performance Liquid ChromatographyPerinatal PharmacokineticsPregnancy-induced Pharmacokinetic ChangesPregnancy-related Pharmacokinetic ChangesPregnancy-related Pharmacokinetics
The purpose of this study was to evaluate the pharmacokinetics of ritonavir-boosted fosamprenavir during pregnancy and postpartum. Amprenavir (the active moiety of fosamprenavir) and ritonavir intensive pharmacokinetic evaluations were performed at steady state during the second and third trimesters of pregnancy and postpartum. Plasma concentrations of amprenavir and ritonavir were measured using high-performance liquid chromatography. The target amprenavir area under the concentration-versus-time curve (AUC) was higher than the 10th percentile (27.
23
Reduced lopinavir exposure during pregnancy
Alice Stek, Mark Mirochnick, Edmund V. Capparelli et al. · AIDS · 2006 · 178 citations
Omar Janneh, E. Jones, Becky Chandler et al. · Journal of Antimicrobial Chemotherapy · 2007 · 101 citations
Brian M. Sadler, Catherine Gillotin, Yu Lou et al. · Antimicrobial Agents and Chemotherapy · 2001 · 98 citations · Full text